According to Titan Pharmaceuticals 's latest financial reports and stock price the company's current number of shares outstanding is 750,800. At the end of 2023 the company had 750,800 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.75 M | 2.65% |
2022 | 0.73 M | 48.31% |
2021 | 0.49 M | 202.21% |
2020 | 0.16 M | 531.07% |
2019 | 0.02 M | 325.14% |
2018 | 0 M | 3.29% |
2017 | 0 M | 0.02% |
2016 | 0 M | 5.67% |
2015 | 0 M | 23.99% |
2014 | 0 M | 7.82% |
2013 | 0 M | 23.5% |
2012 | 0 M | 12.54% |
2011 | 0 M | 0.23% |
2010 | 0 M | 1.63% |
2009 | 0 M | 0.03% |
2008 | 0 M | 31.03% |
2007 | 0 M | 14.36% |
2006 | 0 M | 20.12% |
2005 | 0 M | 0.74% |
2004 | 0 M | 16.26% |
2003 | 0 M | 0% |
2002 | 0 M | 0% |
2001 | 0 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 2,407,200,000 | 320,518.01% | ๐บ๐ธ USA |
Novartis NVS | 2,044,000,000 | 272,142.94% | ๐จ๐ญ Switzerland |
Vanda Pharmaceuticals VNDA | 57,532,309 | 7,562.80% | ๐บ๐ธ USA |
Repligen
RGEN | 55,815,666 | 7,334.16% | ๐บ๐ธ USA |
MediciNova MNOV | 49,046,246 | 6,432.53% | ๐บ๐ธ USA |
Celldex Therapeutics CLDX | 47,261,000 | 6,194.75% | ๐บ๐ธ USA |